Hermetica Superfood Encyclopedia
The Short Answer
Ewe Aje (Gloriosa superba) contains colchicine as its primary bioactive alkaloid, which binds tubulin dimers to inhibit microtubule polymerization, arresting cell division and blocking neutrophil-mediated inflammation. In vitro studies demonstrate cytotoxicity against MDA-MB-231 breast cancer cells at an IC₅₀ of 19.52 µg/mL and antibacterial inhibition zones up to 20 mm against MRSA, though no human clinical trials have validated these effects.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary Keywordewe aje Gloriosa superba benefits
Ewe Aje — botanical close-up
Health Benefits
**Antipyretic Activity**
Traditionally used in Yoruba ethnomedicine to reduce fever; bioactive phenolics and salicylic acid identified in the plant are proposed to modulate prostaglandin synthesis, though mechanistic data in humans is absent.
**Antimicrobial and Anti-Gonorrheal Use**
Yoruba practitioners apply tuber preparations to treat gonorrhea and other infections; in vitro alkaloid and flavonoid fractions inhibit Staphylococcus aureus (MRSA) with inhibition zones of 20 mm, suggesting disruption of bacterial cell wall integrity and protein synthesis.
**Antiparasitic/Head Lice Treatment**
Topical paste preparations of ground tubers are applied to the scalp in Yoruba traditional practice to eliminate head lice; colchicine and associated alkaloids are cytotoxic to rapidly dividing ectoparasite cells, though no controlled efficacy studies exist.
**Anti-Inflammatory Properties**
Purified colchicine inhibits NLRP3 inflammasome activation and blocks neutrophil chemotaxis, mechanisms well-characterized in pharmaceutical colchicine therapy for gout; crude Gloriosa extracts are assumed to share this activity but lack independent clinical validation.
**Anticancer Potential**
Methanolic seed and tuber extracts exert cytotoxicity against MDA-MB-231 breast cancer cells (IC₅₀ 19.52 µg/mL in MTT assay), outperforming doxorubicin in this specific in vitro model, attributed to colchicine-mediated mitotic arrest and tubulin depolymerization.
**Traditional Gout and Arthritis Relief**
Aligned with Ayurvedic and Unani applications, tuber decoctions are used for arthritic and gouty conditions; this parallels the established pharmacology of pharmaceutical colchicine, though crude extract dosing introduces unacceptable toxicity risk.
**Antioxidant Activity**
Flavonoids, tannins, and phenolic compounds identified by GC-MS in seeds and tubers scavenge free radicals and may reduce oxidative stress markers, though quantitative antioxidant data (e.g., DPPH IC₅₀) specific to ewe aje preparations are not yet robustly established.
Origin & History
Natural habitat
Gloriosa superba is native to tropical and southern Africa and Asia, thriving in well-drained, sandy or loamy soils across forest margins, grasslands, and roadsides from West Africa through East Africa, India, and Sri Lanka. In Yoruba-speaking regions of West Africa, it grows as a perennial climbing vine reaching 2–4 meters, with tendrils at leaf tips enabling it to scale surrounding vegetation. The plant is cultivated for both ornamental and pharmaceutical purposes in India, where diverse chemotypes from West Bengal and Sikkim show the highest colchicine concentrations, and it is also harvested wild across Sub-Saharan Africa.
“In Yoruba ethnomedicine of southwestern Nigeria, Gloriosa superba — known as ewe aje — has been used by traditional healers (babalawos) in topical and oral preparations to treat gonorrhea, eliminate head lice, and reduce fever, representing one of several toxic plants employed under controlled knowledge systems where dosage is closely guarded. Across South Asian traditional medicine, the plant is documented in Ayurveda and Unani systems for millennia under names such as Kalihari and Langli, prescribed for arthritis, gout, rheumatism, piles, leprosy, snakebites, and as an abortifacient — uses that align with the potent mitotic-arrest and anti-inflammatory pharmacology of colchicine. Colonial-era botanical surveys in West and East Africa documented the plant's toxicity and its deliberate use in forensic poisoning cases, and it remains a controlled substance or regulated plant in several jurisdictions including Sri Lanka. The flame lily holds national flower status in Zimbabwe and appears in Zimbabwean cultural symbolism, reflecting both its ecological prominence and the dual reverence and caution with which indigenous communities have historically regarded it.”Traditional Medicine
Scientific Research
The scientific evidence base for Gloriosa superba is restricted almost entirely to in vitro and limited animal studies, with no published human randomized controlled trials documenting therapeutic efficacy or safe dosing of crude ewe aje preparations. In vitro anticancer data include an IC₅₀ of 19.52 µg/mL against MDA-MB-231 breast cancer cells using the MTT assay, and antibacterial studies report inhibition zones of up to 20 mm against MRSA from alkaloid-rich fractions; however, sample sizes, replication details, and inter-laboratory consistency are not fully reported in the available literature. Phytochemical characterization studies across 32 Indian chemotypes identified colchicine concentrations ranging from 2.12 to 7.58 mg/g by HPLC, providing quantitative compound data but not therapeutic outcome data. The well-established pharmacology of pharmaceutical-grade colchicine (extensively studied in gout, familial Mediterranean fever, and pericarditis RCTs) is frequently extrapolated to Gloriosa superba, but this extrapolation does not substitute for independent clinical trials on the crude plant material, which carries vastly different pharmacokinetic and safety profiles.
Preparation & Dosage
Traditional preparation
**Traditional Yoruba Poultice**
Fresh or dried tubers are ground into a paste and applied topically to the scalp for head lice; no standardized concentration or application duration is established.
**Decoction (Oral, Traditional)**
Tubers or rhizomes are boiled in water and administered in small volumes for fever or infection; exact volumes and dosing intervals are empirical and culturally transmitted, not clinically validated.
**Methanolic Extract (Research Grade)**
Used in laboratory settings for phytochemical isolation; not intended for human self-administration.
**Pharmaceutical Colchicine (Extracted Active Compound)**
2 mg initially followed by 0
The only safe form for human use; standard dose for acute gout is 1..6 mg one hour later; for gout prophylaxis 0.6 mg once or twice daily, as per pharmaceutical labeling — this does not apply to crude plant use.
**Standardization Note**
58 mg/g); no standardized crude supplement form is commercially approved or safe for consumer use
Colchicine content varies 3.5-fold across chemotypes (2.12–7..
**Timing**
Pharmaceutical colchicine is taken with or without food; crude plant preparations lack evidence-based timing guidance.
**CRITICAL WARNING**
No safe supplemental dose exists for crude Gloriosa superba; the plant is not recommended for self-medication in any form due to narrow therapeutic index and high lethality risk.
Nutritional Profile
Gloriosa superba is not a nutritional food ingredient and provides no meaningful macronutrient content for dietary purposes. Its phytochemical profile includes colchicine (0.57% in tubers, 0.6–0.9% in seeds by dry weight; 2.12–7.58 mg/g across chemotypes), colchicoside, gloriosine, superbine, lumicolchicine, and 3-demethylcolchicine as the primary alkaloid constituents. Secondary metabolites identified by GC-MS include β-sitosterol, flavonoids, saponins, tannins, phenolic acids, salicylic acid, sterols, and fatty acids — 9 compounds characterized in tubers and 17 in seeds across analytical studies. Colchicine is orally bioavailable with approximately 45% intestinal absorption, extensive tissue distribution (volume of distribution ~5–8 L/kg), and hepatic metabolism via CYP3A4 with biliary excretion; the narrow therapeutic index (lethal dose ~0.5–0.8 mg/kg colchicine) makes bioavailability a critical toxicological rather than nutritional consideration.
How It Works
Mechanism of Action
Colchicine, the primary alkaloid in Gloriosa superba (0.57–0.9% in tubers and seeds), binds with high affinity to the colchicine-binding site on β-tubulin, preventing GTP-dependent tubulin polymerization into microtubules and thereby arresting mitosis at the metaphase stage; this mechanism underlies both its cytotoxic anticancer activity and its capacity to induce polyploidy in dividing cells. Simultaneously, colchicine reduces inflammation by inhibiting NLRP3 inflammasome assembly and suppressing IL-1β secretion, blocking neutrophil microtubule-dependent chemotaxis, and downregulating NF-κB-mediated pro-inflammatory cytokine expression. Antibacterial alkaloids, flavonoids, and phenolics in crude extracts disrupt bacterial cell membrane integrity, inhibit bacterial protein synthesis via ribosomal interference, and intercalate into bacterial DNA to impair nucleic acid replication, as evidenced by in vitro disk diffusion assays against MRSA and other pathogens. The abortifacient and antipyretic activities are attributed to colchicine-driven disruption of mitotic spindle formation in trophoblastic cells and to salicylic acid-mediated cyclooxygenase inhibition reducing prostaglandin-induced fever, respectively.
Clinical Evidence
No clinical trials with defined human sample sizes, randomization, or controlled designs have been conducted specifically on Gloriosa superba or its traditional preparations including ewe aje. Evidence for anti-inflammatory and anticancer activity is inferred entirely from in vitro cytotoxicity assays (IC₅₀ 19.52 µg/mL, breast cancer cells) and mechanistic studies on its primary constituent, pharmaceutical colchicine, which has been validated in large RCTs for gout (e.g., AGREE trial) and acute pericarditis (COPE trial) at precisely controlled doses. The critical gap is that crude plant extracts contain variable colchicine concentrations (2.12–7.58 mg/g across chemotypes), making therapeutic dosing without extraction and standardization impossible and clinically unsafe. Until controlled human trials using standardized extracts of defined colchicine content are conducted, confidence in efficacy claims for ewe aje as a therapeutic agent remains very low.
Safety & Interactions
Gloriosa superba is highly toxic across all plant parts, with colchicine concentrations sufficient to cause fatal poisoning through ingestion of small amounts of tuber or seed material; clinical toxidrome includes severe nausea, vomiting, watery diarrhea, hypotension, acute respiratory failure, multi-organ dysfunction, myelosuppression, alopecia, and death at colchicine exposures of approximately 0.5–0.8 mg/kg body weight. Drug interactions are significant and inferred from established colchicine pharmacology: co-administration with CYP3A4 inhibitors (clarithromycin, ketoconazole, ritonavir) or P-glycoprotein inhibitors (cyclosporine, verapamil) dramatically increases colchicine plasma levels and toxicity risk; concurrent statin use raises the risk of rhabdomyolysis. The plant is absolutely contraindicated in pregnancy, as colchicine is a potent abortifacient and teratogen disrupting mitotic spindle formation in fetal cells, and is contraindicated in patients with renal or hepatic impairment due to reduced colchicine clearance, as well as in children and breastfeeding individuals. No safe consumer supplemental dose has been established; all traditional use carries substantial risk without expert preparation and knowledge, and any suspected ingestion should prompt immediate medical evaluation.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Gloriosa superbaFlame LilyGlory LilyKalihariLangliClimbing LilyCreeping LilyMalabar Glory Lily
Frequently Asked Questions
What is ewe aje used for in Yoruba traditional medicine?
In Yoruba ethnomedicine, ewe aje (Gloriosa superba) is primarily used to treat gonorrhea, eliminate head lice through topical scalp applications, and reduce fever as an antipyretic. Traditional healers prepare the tubers as ground pastes or decoctions, though these uses are based entirely on empirical knowledge passed through generations and have not been validated in controlled clinical trials.
Is Gloriosa superba safe to use as a supplement or herbal remedy?
Gloriosa superba is not safe for use as a self-administered supplement or herbal remedy; all parts of the plant contain colchicine at concentrations capable of causing fatal poisoning, with a lethal dose of approximately 0.5–0.8 mg/kg colchicine. Ingestion can cause severe vomiting, diarrhea, multi-organ failure, myelosuppression, and death, and no standardized safe consumer dose has been established by any regulatory authority.
What is the main active compound in Gloriosa superba and how does it work?
The primary active compound is colchicine, present at 0.57% in tubers and up to 0.9% in seeds by dry weight, which works by binding to the colchicine-binding site on β-tubulin and preventing microtubule polymerization, thereby arresting cell division at metaphase. This mechanism explains both the plant's cytotoxic anticancer activity and its anti-inflammatory effects, which occur through inhibition of neutrophil chemotaxis and NLRP3 inflammasome activation.
Does Gloriosa superba have anticancer properties?
In vitro studies show that methanolic extracts of Gloriosa superba exhibit cytotoxicity against MDA-MB-231 human breast cancer cells with an IC₅₀ of 19.52 µg/mL in the MTT assay, a result described as superior to doxorubicin in that specific experimental model. However, no animal efficacy studies or human clinical trials have confirmed these findings, and in vitro cytotoxicity data cannot be directly translated to clinical anticancer benefit.
What drug interactions does colchicine in Gloriosa superba cause?
Colchicine from Gloriosa superba is metabolized by CYP3A4 and is a substrate of P-glycoprotein, meaning that CYP3A4 inhibitors such as clarithromycin, ketoconazole, and ritonavir can dramatically increase colchicine plasma concentrations and precipitate life-threatening toxicity. Co-administration with P-glycoprotein inhibitors including cyclosporine and verapamil carries similar risk, and concurrent statin use increases the probability of colchicine-induced rhabdomyolysis; these interactions apply to crude plant preparations as well as pharmaceutical colchicine.
Is Ewe Aje safe during pregnancy and breastfeeding?
Gloriosa superba is contraindicated during pregnancy and breastfeeding due to its colchicine content, which poses risks of miscarriage and fetal toxicity. The alkaloids in the plant can pass into breast milk and affect nursing infants. Traditional use does not establish safety for these vulnerable populations, and medical supervision is essential before any consideration of use.
What is the evidence quality for Ewe Aje's antipyretic and antimicrobial effects?
While Yoruba ethnomedicine documents traditional antipyretic and anti-gonorrheal applications of Gloriosa superba, most evidence remains limited to in vitro studies and phytochemical analysis rather than human clinical trials. Bioactive phenolics and salicylic acid have been identified in the plant with proposed mechanisms for fever reduction, but mechanistic validation in humans is absent. Current evidence is insufficient to support therapeutic claims without further rigorous clinical research.
Who should avoid Ewe Aje supplementation due to safety concerns?
Individuals with kidney or liver disease, gastrointestinal conditions, pregnant or breastfeeding women, and children should avoid Gloriosa superba due to its colchicine toxicity and lack of safety data in these populations. Patients taking medications metabolized by the liver or those with a history of colchicine sensitivity require absolute avoidance. The narrow margin between therapeutic and toxic doses makes this ingredient particularly risky for unsupervised use.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w ewe-aje-gloriosa-superba curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
